Related stories
Hanjoo ART Faces Kosdaq Delisting Eligibility Review
Hanjoo ART faces a Kosdaq listing eligibility review over potential delisting.
L impact | REGULATION | Nov 19, 2026, 07:55 AM UTC
SEBI Approves Transfer of PMS Business to ICICI Prudential Asset Management
SEBI approved the transfer of the portfolio management services business from ICICI Securities to ICICI Prudential Asset Management.
M impact | REGULATION | Nov 19, 2026, 07:29 AM UTC
FDA Grants Priority Review to AstraZeneca’s Sonesitatug Vedotin
The FDA granted priority review to AstraZeneca’s sonesitatug vedotin for advanced gastric cancers.
L impact | REGULATION | Nov 19, 2026, 07:14 AM UTC
Sonesitatug Vedotin Granted Priority Review in the US
The application covers second- and later-line treatment of patients with CLDN18.2-positive advanced gastric or gastroesophageal junction cancers.
L impact | REGULATION | Nov 19, 2026, 07:01 AM UTC
Taiwan to Enact New Short-Selling Curbs After Market Drop
Taiwan plans new short-selling curbs in response to a market drop.
M impact | REGULATION | Nov 19, 2026, 07:01 AM UTC
European Commission Approves Sanofi’s VaxRabeo for Rabies Prevention
The European Commission approved Sanofi’s VaxRabeo for rabies prophylaxis for all ages.
M impact | REGULATION | Nov 19, 2026, 06:00 AM UTC